Welcome to the June 2018 edition of our Updates on Myeloproliferative Neoplasms (MPNs) newsletter. I’d like to kick things off by presenting my interview with Samantha—a patient of mine who was diagnosed with an MPN at a young age and has been managing her disease for the past 15 years. She and I recently chatted about her MPN diagnosis and long-term management, how advanced practitioners have influenced her care, and why communication is key throughout the entire process. I hope you enjoy our conversation and take away valuable insights from the patient perspective to use in your practice.
This month, we also provide links to articles on a recent survey about the employment and work productivity of patients with MPNs; a discussion of the diagnostic, prognostic, and treatment implications of mutation profiling for MPNs; and thoughts on the future of genetic profiling for MPNs.
Make sure to check out our full roundtable panel discussion, “Management of Myeloproliferative Neoplasms: A Case-Based Discussion,” and our “Fast Facts” guides —helpful and informative PDFs of MPN incidence and mortality data as well as World Health Organization diagnostic criteria.
Please feel free to share this newsletter with your colleagues, and don’t hesitate to get in touch with me with comments or suggestions through the JADPRO editors at email@example.com at any time.
Lindsey Lyle, MS, PA-C
University of Colorado, Anschutz Medical Campus